Latest Advisory

  • FDA Advisory No. 2017-013 || Reiteration of the Public Health Warning Against the Use of Max Factor Eye Brightening Mascara

    FDA Advisory No. 2017-013 || Reiteration of the Public Health Warning Against the Use of Max Factor Eye Brightening Mascara

    Read more

  • FDA Advisory No. 2017-012 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 10

    FDA Advisory No. 2017-012 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 10

    Read more

  • FDA Advisory No. 2017-011 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 9)

    FDA Advisory No. 2017-011 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 9)

    Read more

  • FDA Advisory No. 2017-010 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 8)

    FDA Advisory No. 2017-010 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 8)

    Read more

  • FDA Advisory No. 2017-009 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 7)

    FDA Advisory No. 2017-009 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 7)

    Read more

  • FDA Advisory No. 2017-008 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 6)

    FDA Advisory No. 2017-008 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 6)

    Read more

  • FDA Advisory No. 2017-007 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 5)

    FDA Advisory No. 2017-007 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 5)

    Read more

  • FDA Advisory No. 2017-006 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 4)

    FDA Advisory No. 2017-006 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 4)

    Read more

  • FDA Advisory No. 2017-005 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 3)

    FDA Advisory No. 2017-005 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 3)

    Read more

  • FDA Advisory No. 2017-004 || Public Health Warning Against the Use of Unregistered Household/Urban Pesticide Products (batch 7)

    FDA Advisory No. 2017-004 || Public Health Warning Against the Use of Unregistered Household/Urban Pesticide Products (batch 7)

    Read more

  • FDA Advisory No. 2017-003 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 2)

    FDA Advisory No. 2017-003 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 2)

    Read more

  • FDA Advisory No. 2017-002 || Lifting of FDA Advisory No. 2016-143 and 2016-143-A, “Public Health Warning Against the Use of Unregistered Drug Product Puritan’s Pride Folic Acid 400 mcg Tablet”

    FDA Advisory No. 2017-002 || Lifting of FDA Advisory No. 2016-143 and 2016-143-A, “Public Health Warning Against the Use of Unregistered Drug Product Puritan’s Pride Folic Acid 400 mcg Tablet”

    Read more

  • FDA Advisory No. 2017-001 || Public Warning Against the Facebook Group “DAIRY GOAT PHILIPPINES” for Promoting Dairy Goat as Breastmilk Substitute for Infants and Violating Executive Order No. 51 or the “Milk Code of the Philippines”

    FDA Advisory No. 2017-001 || Public Warning Against the Facebook Group “DAIRY GOAT PHILIPPINES” for Promoting Dairy Goat as Breastmilk Substitute for Infants and Violating Executive Order No. 51 or the “Milk Code of the Philippines”

    Read more

  • FDA Advisory No. 2016-146 || Public Health Advisory on Lead-Cored Wick Candles

    FDA Advisory No. 2016-146 || Public Health Advisory on Lead-Cored Wick Candles

    Read more

  • FDA Advisory No. 2016-145 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 23)

    FDA Advisory No. 2016-145 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 23)

    Read more

  • FDA Advisory No. 2016-144-A || Babala sa Publiko Tungkol sa Paggamit ng Hindi Rehistradong Gamot na “Sevelamer Hydrochloride (Sevel) 400 mg Tablet” na gawa ng The ACME Laboratories Ltd. – Dhaka, Bangladesh

    FDA Advisory No. 2016-144-A || Babala sa Publiko Tungkol sa Paggamit ng Hindi Rehistradong Gamot na “Sevelamer Hydrochloride (Sevel) 400 mg Tablet” na gawa ng The ACME Laboratories Ltd. – Dhaka, Bangladesh

    Read more

  • FDA Advisory No. 2016-144 || Public Health Warning Against the Use of the Unregistered Drug Product “Sevelamer Hydrochloride (Sevel) 400 mg Tablet” manufactured by The ACME Laboratories Ltd. – Dhaka, Bangladesh

    FDA Advisory No. 2016-144 || Public Health Warning Against the Use of the Unregistered Drug Product “Sevelamer Hydrochloride (Sevel) 400 mg Tablet” manufactured by The ACME Laboratories Ltd. – Dhaka, Bangladesh

    Read more

  • FDA Advisory No. 2016-142-A || Babala sa Publiko Tungkol sa Paggamit ng mga Hindi Rehistradong Gamot na:

    FDA Advisory No. 2016-142-A || Babala sa Publiko Tungkol sa Paggamit ng mga Hindi Rehistradong Gamot na:

    Read more

  • FDA Advisory No. 2016-142 || Public Health Warning Against the Use of the Following Unregistered Drug Products:

    FDA Advisory No. 2016-142 || Public Health Warning Against the Use of the Following Unregistered Drug Products:

    Read more

  • FDA Advisory No. 2016-141-A || Babala sa Publiko tungkol sa Paggamit ng mga Pekeng Gamot na:

    FDA Advisory No. 2016-141-A || Babala sa Publiko tungkol sa Paggamit ng mga Pekeng Gamot na:

    Read more

Additional Requirements on Applying Export / Commodity Clearance

In order the better facilitate the processing of your application for Export/Commodity Clearance the FDA-CSL would like to inform you the additional requirements need to be submitted:

Flash Drive or Pen Drive (USB) containing duly accomplished forms which are downloadable from the FDA Website under Common Services Laboratory (http://www.fda.gov.ph/industry-corner/downloadables):

  1. Export/Commodity Clearance Database
  2. Draft Export/Commodity Clearance Certificate

The Above requirements to be included in the receiving for Export/Commodity Clearance application shall enable our staff to prepare the certificate within our committed time (as reflected in the attached process flow) instead of having individually consumes bulk of our man-hour.

This shall effect immediately upon posting in the FDA Website.

For your information and guidance

Share Us on

Submit to FacebookSubmit to Google PlusSubmit to Twitter